Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1967 2
1968 3
1969 9
1970 5
1971 4
1972 4
1973 8
1974 8
1975 11
1976 9
1977 18
1978 19
1979 15
1980 16
1981 22
1982 18
1983 44
1984 30
1985 36
1986 31
1987 37
1988 26
1989 46
1990 39
1991 56
1992 47
1993 42
1994 50
1995 46
1996 31
1997 39
1998 35
1999 24
2000 40
2001 27
2002 27
2003 26
2004 21
2005 31
2006 15
2007 20
2008 16
2009 20
2010 15
2011 13
2012 17
2013 15
2014 8
2015 10
2016 7
2017 6
2018 4
2019 6
2020 3
2021 8
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

1,166 results

Results by year

Filters applied: . Clear all
Page 1
Prevention of Preterm Labor by Isosorbide Dinitrate and Nitroglycerin Patch.
Ghafarzadeh M, Shakarami A, Yari F. Ghafarzadeh M, et al. Cardiovasc Hematol Disord Drug Targets. 2023;23(2):130-135. doi: 10.2174/1871529X23666230818092437. Cardiovasc Hematol Disord Drug Targets. 2023. PMID: 37594102 Clinical Trial.
OBJECTIVE: This study aims to compare the effect of transdermal nitroglycerin (TNG) patches and sublingual tablets of Isosorbide dinitrate (ISD) for the prevention of preterm delivery. METHODS: A total of 110 healthy pregnant women aged 18-35 years with a healthy an …
OBJECTIVE: This study aims to compare the effect of transdermal nitroglycerin (TNG) patches and sublingual tablets of Isosorbide d
Isosorbide dinitrate and nifedipine in variant angina pectoris.
Conti CR, Hill JA, Feldman RL, Conti JB, Pepine CJ. Conti CR, et al. Am Heart J. 1985 Jul;110(1 Pt 2):251-6. doi: 10.1016/0002-8703(85)90495-8. Am Heart J. 1985. PMID: 3925744 Review.
The efficacy of isosorbide dinitrate (ISDN) in variant angina is enhanced by the addition of a calcium antagonist. ...
The efficacy of isosorbide dinitrate (ISDN) in variant angina is enhanced by the addition of a calcium antagonist. ...
Effects of Cilostazol and Isosorbide Mononitrate on Cerebral Hemodynamics in the LACI-1 Randomized Controlled Trial.
Blair GW, Janssen E, Stringer MS, Thrippleton MJ, Chappell F, Shi Y, Hamilton I, Flaherty K, Appleton JP, Doubal FN, Bath PM, Wardlaw JM. Blair GW, et al. Stroke. 2022 Jan;53(1):29-33. doi: 10.1161/STROKEAHA.121.034866. Epub 2021 Dec 1. Stroke. 2022. PMID: 34847709 Free PMC article. Clinical Trial.
BACKGROUND AND PURPOSE: Cerebral small vessel disease-a major cause of stroke and dementia-is associated with cerebrovascular dysfunction. We investigated whether short-term isosorbide mononitrate (ISMN) and cilostazol, alone or in combination, improved magnetic resonance …
BACKGROUND AND PURPOSE: Cerebral small vessel disease-a major cause of stroke and dementia-is associated with cerebrovascular dysfunction. W …
A new isosorbide dinitrate extended-release formulation: pharmacokinetic and clinical parameters in patients with stable angina pectoris.
Klemsdal TO, Mundal HH, Rudberg N, Gjesdal K. Klemsdal TO, et al. Eur J Clin Pharmacol. 1994;47(4):351-4. doi: 10.1007/BF00191167. Eur J Clin Pharmacol. 1994. PMID: 7875187 Clinical Trial.
In a double-blind, cross-over study the acute clinical efficacy and pharmacokinetic profile of a newly developed isosorbide dinitrate extended-release (ISDN-ER) formulation (10 mg immediate release and 60 mg slow release) were examined in eight angina patients. ...P …
In a double-blind, cross-over study the acute clinical efficacy and pharmacokinetic profile of a newly developed isosorbide dinitr
Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment.
Schneider W, Maul FD, Bussmann WD, Lang E, Hör G, Kaltenbach M. Schneider W, et al. Eur Heart J. 1988 Feb;9(2):149-58. doi: 10.1093/oxfordjournals.eurheartj.a062468. Eur Heart J. 1988. PMID: 3280317 Review.
Fourteen male patients with exertion-related angina pectoris and reproducible ST-segment depression on stress testing were each treated with isosorbide dinitrate (ISDN) 40 mg three times daily, verapamil 120 mg three times daily and placebo three times daily for two …
Fourteen male patients with exertion-related angina pectoris and reproducible ST-segment depression on stress testing were each treated with …
Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Neuhaus R, Johnen R, Vydra L, Solbach C. Neuhaus R, et al. Pharmatherapeutica. 1986;4(8):486-95. Pharmatherapeutica. 1986. PMID: 3086899 Clinical Trial.
A double-blind crossover study, with placebo periods preceding each active treatment, was carried out in 29 patients with ischaemic heart disease to compare the clinical efficacy of isosorbide 5-mononitrate 40 mg twice daily and the same regimen of sustained-release iso
A double-blind crossover study, with placebo periods preceding each active treatment, was carried out in 29 patients with ischaemic heart di …
Nitrate tolerance.
Parker JO. Parker JO. Herz. 1984 Jun;9(3):137-45. Herz. 1984. PMID: 6430767 Clinical Trial.
Tolerance is rapidly reversed and the return of normal responsiveness is seen within 21 hours withdrawal of isosorbide dinitrate. Cross-tolerance occurs between the hemodynamic effects of isosorbide dinitrate and nitroglycerin. ...Sublingual isosorb
Tolerance is rapidly reversed and the return of normal responsiveness is seen within 21 hours withdrawal of isosorbide dinitrate
Double-blind randomised crossover trial comparing isosorbide dinitrate cream and oral sustained-release tablets in patients with angina pectoris.
Handler CE, Sullivan ID. Handler CE, et al. Int J Cardiol. 1985 Feb;7(2):149-57. doi: 10.1016/0167-5273(85)90356-0. Int J Cardiol. 1985. PMID: 3882583 Clinical Trial.
Percutaneous isosorbide dinitrate cream and sustained-release tablets were compared in a double-blind randomised crossover trial in 28 patients with coronary artery disease and chronic stable angina pectoris. ...Equal numbers of patients expressed preference for cre …
Percutaneous isosorbide dinitrate cream and sustained-release tablets were compared in a double-blind randomised crossover tri …
Isosorbide-5-mononitrate and isosorbide dinitrate retard in the treatment of coronary heart disease: a multi-centre study.
Bidoggia H. Bidoggia H. Curr Med Res Opin. 1987;10(9):601-11. doi: 10.1185/03007998709112414. Curr Med Res Opin. 1987. PMID: 3325229 Clinical Trial.
A multi-centre study was carried out in 200 coronary patients to compare the efficacy and tolerance of isosorbide dinitrate retard (40 mg) and isosorbide-5-mononitrate (20 mg) with regard to the frequency of anginal attacks and consumption of sub-lingual (sho …
A multi-centre study was carried out in 200 coronary patients to compare the efficacy and tolerance of isosorbide dinitrate re …
Intravaginal administration of isosorbide mononitrate for cervical ripening in prolonged pregnancy: a randomised clinical trial.
Mirteimouri M, Pourali L, Najaf Najafi M, Ghaffarian Omid M. Mirteimouri M, et al. J Obstet Gynaecol. 2020 Aug;40(6):792-796. doi: 10.1080/01443615.2019.1669546. Epub 2019 Dec 18. J Obstet Gynaecol. 2020. PMID: 31852287 Clinical Trial.
This study was performed to evaluate the efficacy of intravaginal isosorbide mononitrate (IMN) for cervical ripening in prolonged pregnancies. 122 pregnant women were recruited. ...According to results of the current study; using isosorbide mononitrate in combinatio …
This study was performed to evaluate the efficacy of intravaginal isosorbide mononitrate (IMN) for cervical ripening in prolonged pre …
1,166 results